Mapping the Pathway for Trials on Healthy Longevity

Mapping the Pathway for Trials on Healthy Longevity - Watch the roundtable now.

At ICFSR 2026, held March 11–13 at the Johns Hopkins Bloomberg Center in Washington, DC, one of the most anticipated sessions brought together leading voices from regulatory science, government research, and the pharmaceutical industry to address a defining challenge for the field.

Mapping the Pathway for Trials on Healthy Longevity

Chaired by Jamie Justice (XPRIZE Healthspan), the roundtable featured:

  • Susan C. Winckler – Reagan-Udall Foundation for the FDA, Washington, DC
  • Andrew Brack – ARPA-H
  • Jonathan Levi – AstraZeneca Pharmaceuticals, Gaithersburg
  • Alfred Gellhorn – GSK, Philadelphia, PA